Polarized expression of members of the solute carrier SLC19A gene family of water-soluble multivitamin transporters:: implications for physiological function

被引:34
|
作者
Boulware, MJ
Subramanian, VS
Said, HM
Marchant, JS
机构
[1] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA
[2] Univ Calif Irvine, Dept Med & Physiol, Irvine, CA 92697 USA
[3] Vet Adm Med Ctr, Long Beach, CA 90822 USA
关键词
folate; polarity; thiamine; transport; vitamin;
D O I
10.1042/BJ20031220
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Humans lack biochemical pathways for the synthesis of the micro-nutrients thiamine and folate. Cellular requirements are met through membrane transport activity, which is mediated by proteins of the SLC19A gene family. By using live-cell confocal imaging methods to resolve the localization of all SLC19A family members, we show that the two human thiamine transporters are differentially targeted in polarized cells, establishing a vectorial transport system. Such polarization decreases functional redundancy between transporter isoforms and allows for independent regulation of thiamine import and export pathways in cells.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 3 条
  • [1] Human adipose tissue gene expression of solute carrier family 19 member 3 (SLC19A3); relation to obesity and weight-loss
    Pereira, Maria J.
    Andersson-Assarsson, Johanna C.
    Jacobson, Peter
    Kamble, Prasad
    Taube, Magdalena
    Sjoholm, Kajsa
    Carlsson, Lena M. S.
    Svensson, Per-Arne
    OBESITY SCIENCE & PRACTICE, 2022, 8 (01): : 21 - 31
  • [2] Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers
    Petakh, Pavlo
    Kamyshna, Iryna
    Kamyshnyi, Aleksandr
    INFLAMMOPHARMACOLOGY, 2024, 32 (01) : 885 - 891
  • [3] Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers
    Pavlo Petakh
    Iryna Kamyshna
    Aleksandr Kamyshnyi
    Inflammopharmacology, 2024, 32 : 885 - 891